Misonix Inc (MSON) Stock Price & Overview
NASDAQ:MSON
Current stock price
The current stock price of MSON is 26.54 null. Today MSON is up by 4.74%. In the past month the price increased by 4.9%. In the past year, price increased by 133.63%.
MSON Key Statistics
- Market Cap
- 462.061M
- P/E
- N/A
- Fwd P/E
- N/A
- EPS (TTM)
- -0.84
- Dividend Yield
- N/A
MSON Stock Performance
MSON Stock Chart
MSON Technical Analysis
ChartMill assigns a technical rating of 8 / 10 to MSON. When comparing the yearly performance of all stocks, MSON is one of the better performing stocks in the market, outperforming 90.14% of all stocks.
MSON Fundamental Analysis
ChartMill assigns a fundamental rating of 4 / 10 to MSON. MSON scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages.
MSON Earnings
MSON Forecast & Estimates
3 analysts have analysed MSON and the average price target is 28.56 null. This implies a price increase of 7.61% is expected in the next year compared to the current price of 26.54.
For the next year, analysts expect an EPS growth of 10.14% and a revenue growth 16.14% for MSON
MSON Groups
Sector & Classification
MSON Financial Highlights
Over the last trailing twelve months MSON reported a non-GAAP Earnings per Share(EPS) of -0.84. The EPS increased by 16% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | -19.55% | ||
| ROA | -7.28% | ||
| ROE | N/A | ||
| Debt/Equity | 0.29 |
MSON Ownership
MSON Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 18.36 | 186.262B | ||
| ISRG | INTUITIVE SURGICAL INC | 46.76 | 170.438B | ||
| SYK | STRYKER CORP | 22.19 | 130.023B | ||
| BSX | BOSTON SCIENTIFIC CORP | 19.87 | 103.709B | ||
| EW | EDWARDS LIFESCIENCES CORP | 27.38 | 47.893B | ||
| IDXX | IDEXX LABORATORIES INC | 38.94 | 46.168B | ||
| BDX | BECTON DICKINSON AND CO | 11.31 | 44.57B | ||
| RMD | RESMED INC | 18.4 | 33.129B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 13.48 | 32.076B | ||
| DXCM | DEXCOM INC | 26.33 | 25.89B | ||
| ZBH | ZIMMER BIOMET HOLDINGS INC | 10.36 | 17.577B | ||
| HOLX | HOLOGIC INC | 15.36 | 16.817B | ||
| PODD | INSULET CORP | 35.13 | 16.096B |
Related stock screener links
View all stocks in the Health Care Equipment Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About MSON
Company Profile
Misonix, Inc. is a medical device company, which engages in the design, development, manufacture and marketing of therapeutic ultrasonic medical devices. The company is headquartered in Farmingdale, New York and currently employs 281 full-time employees. The firm is engaged in designing, manufacturing and marketing of minimally invasive therapeutic ultrasonic medical devices. Its products include BoneScalpel Surgical System (BoneScalpel), SonicOne Wound Cleansing and Debridement System (SonicOne) and SonaStar Surgical Aspirator (SonaStar). BoneScalpel is used for surgical procedures involving the precise cutting and sculpting of bone while sparing soft tissue. SonaStar is used to emulsify and remove soft and hard tumors, primarily in the neuro and general surgery field. SonicOne offers tissue specific debridement and cleansing of wounds and burns for effective removal of devitalized tissue and fibrin deposits while sparing viable cells. The Company’s products are nexus, BoneScalpel, SonaStar, SonicOne, TheraSkin and Therion.
Company Info
IPO: 1992-01-23
Misonix Inc
1938 New Hwy
Farmingdale NEW YORK 11735 US
CEO: Stavros G. Vizirgianakis
Employees: 281
Phone: 16319279113.0
Misonix Inc / MSON FAQ
Can you describe the business of Misonix Inc?
Misonix, Inc. is a medical device company, which engages in the design, development, manufacture and marketing of therapeutic ultrasonic medical devices. The company is headquartered in Farmingdale, New York and currently employs 281 full-time employees. The firm is engaged in designing, manufacturing and marketing of minimally invasive therapeutic ultrasonic medical devices. Its products include BoneScalpel Surgical System (BoneScalpel), SonicOne Wound Cleansing and Debridement System (SonicOne) and SonaStar Surgical Aspirator (SonaStar). BoneScalpel is used for surgical procedures involving the precise cutting and sculpting of bone while sparing soft tissue. SonaStar is used to emulsify and remove soft and hard tumors, primarily in the neuro and general surgery field. SonicOne offers tissue specific debridement and cleansing of wounds and burns for effective removal of devitalized tissue and fibrin deposits while sparing viable cells. The Company’s products are nexus, BoneScalpel, SonaStar, SonicOne, TheraSkin and Therion.
What is the stock price of Misonix Inc today?
The current stock price of MSON is 26.54 null. The price increased by 4.74% in the last trading session.
Does Misonix Inc pay dividends?
MSON does not pay a dividend.
How is the ChartMill rating for Misonix Inc?
MSON has a ChartMill Technical rating of 8 out of 10 and a ChartMill Fundamental rating of 4 out of 10.
What do analysts say about Misonix Inc (MSON) stock?
3 analysts have analysed MSON and the average price target is 28.56 null. This implies a price increase of 7.61% is expected in the next year compared to the current price of 26.54.
Is Misonix Inc (MSON) stock a good buy?
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on MSON.
Can you provide the market cap for Misonix Inc?
Misonix Inc (MSON) has a market capitalization of 462.06M null. This makes MSON a Small Cap stock.